ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,791Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 551

$765K Total Retail Price of All Prescriptions

Rank: 36 out of 551

468 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 15,250 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,223 1,039 1 1
AMLODIPINE BESYLATE 821 720 2 4
OMEPRAZOLE 819 707 3 7
GABAPENTIN 788 694 4 3
RANITIDINE HCL 756 660 5 8
LOSARTAN-HYDROCHLOROTHIAZIDE 751 608 6 10
SYNTHROID 707 562 7 11
METFORMIN HCL 553 459 8 2
LOSARTAN POTASSIUM 447 436 9 6
GLIMEPIRIDE 385 332 10 16
EVISTA 340 294 11 52
METOPROLOL SUCCINATE 339 285 12 23
TRAMADOL HCL-ACETAMINOPHEN 334 309 13 18
FENOFIBRATE 305 269 14 34
AMLODIPINE BESYLATE-BENAZEPRIL 288 277 15 42
DICLOFENAC POTASSIUM 230 178 16 45
METOPROLOL TARTRATE 219 173 17 17
ALENDRONATE SODIUM 219 203 17 19
JANUMET 210 172 19 109
SERTRALINE HCL 192 163 20 43
ENALAPRIL MALEATE 191 139 21 5
DONEPEZIL HCL 186 185 22 50
ATENOLOL 174 165 23 12
HYDROCHLOROTHIAZIDE 168 159 24 15
FUROSEMIDE 168 164 24 13
PANTOPRAZOLE SODIUM 160 140 26 36
GLYBURIDE-METFORMIN HCL 153 138 R 27 48
ZOLPIDEM TARTRATE 152 142 28 27
ZETIA 149 123 29 69
CRESTOR 137 115 30 62
VYTORIN 137 121 30 132
TAMSULOSIN HCL 136 117 32 38
LANTUS 132 115 33 28
CLOPIDOGREL 122 107 34 30
MAXIMUM D3 116 73 35 103
IRBESARTAN 108 95 36 51
NABUMETONE 105 81 37 37
FAMOTIDINE 104 103 38 31
HUMALOG MIX 75-25 100 82 39 110
PAROXETINE HCL 98 77 40 77
NAMENDA 95 95 41 94
DOXAZOSIN MESYLATE 95 87 41 25
CARVEDILOL 94 84 43 22
INSULIN SYRINGE 91 89 44 41
ALLOPURINOL 91 81 44 84
LEVOTHYROXINE SODIUM 90 65 46 9
ATORVASTATIN CALCIUM 89 79 47 29
PLAVIX 86 78 48 33
SUCRALFATE 84 68 49 120
MECLIZINE HCL 82 72 50 56
ISOSORBIDE MONONITRATE ER 81 81 51 21
BENAZEPRIL HCL 81 81 51 183
LISINOPRIL 79 66 53 14
CYMBALTA 77 65 54 105
HUMALOG 77 76 54 101
SINGULAIR 72 64 56 58
SULINDAC 68 50 57 78
TRILIPIX 66 37 58 158
MELOXICAM 64 51 59 90
GLIPIZIDE 63 44 60 20
WARFARIN SODIUM 57 47 61 46
JANUVIA 54 42 62 87
ASPIRIN EC 54 51 62 26
AVAPRO 53 53 64 83
IBANDRONATE SODIUM 53 50 64 166
LYRICA 52 37 66 86
LANTUS SOLOSTAR 51 51 67 284
DIGOXIN 51 51 67 44
DIOVAN HCT 50 44 69 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.